[Federal Register Volume 88, Number 48 (Monday, March 13, 2023)]
[Rules and Regulations]
[Pages 15279-15289]
[FR Doc No: 2023-03830]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 180

[EPA-HQ-OPP-2020-0297; FRL-10642-01-OCSPP]

Various Fragrance Components in Pesticide Formulations; Tolerance
Exemption

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This regulation establishes exemptions from the requirement of
a tolerance for residues of various fragrance components listed in Unit
II of this document when used as inert ingredients in antimicrobial
pesticide formulations applied to food-contact surfaces in public
eating places, dairy-processing equipment, and food-processing
equipment and utensils when the end-use concentration does not exceed
100 parts per million (ppm). Innovative Reform Group, on behalf of The
Clorox Company, submitted a petition to EPA under the Federal Food,
Drug, and Cosmetic Act (FFDCA), requesting establishment of exemptions
from the requirement of a tolerance. This regulation eliminates the
need to establish a maximum permissible level for residues of these
various fragrance components, when used in accordance with the terms of
the exemptions.

DATES: This regulation is effective March 13, 2023. Objections and
requests for hearings must be received on or before May 12, 2023 and
must be filed in accordance with the instructions provided in 40 CFR
part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).

ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2020-0297, is available at
https://www.regulations.gov or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket) in the Environmental Protection
Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg.,
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC 20460-0001. The
Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room and the OPP docket is<PHONE_NUMBER>. For the latest
status information on EPA/DC services, docket access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Daniel Rosenblatt, Registration
Division (7505T), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; main telephone number:<PHONE_NUMBER>; email address:
[email protected].

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
     Crop production (NAICS code 111).
     Animal production (NAICS code 112).
     Food manufacturing (NAICS code 311).
     Pesticide manufacturing (NAICS code 32532).

B. How can I get electronic access to other related information?

    You may access a frequently updated electronic version of 40 CFR
part 180 through the Office of the Federal Register's e-CFR site at
https://www.ecfr.gov/current/title-40.

C. How can I file an objection or hearing request?

    Under FFDCA section 408(g), 21 U.S.C. 346a(g), any person may file
an objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2020-0297 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing and must be received by the Hearing Clerk on or before
May 12, 2023. Addresses for mail and hand delivery of objections and
hearing requests are provided in 40 CFR 178.25(b).
    In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2020-0297, by one of
the following methods:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
     Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001.
     Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/where-send-comments-epa-dockets.
    Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.

II. Petition for Exemption

    In the Federal Register of June 24, 2020 (85 FR 37806) (FRL-10010-
82), EPA issued a document pursuant to FFDCA section 408, 21 U.S.C.
346a, announcing the filing of a pesticide petition (PP IN-11372) by
Innovative Reform Group on behalf of The Clorox Company, 4900 Johnson
Dr., Pleasanton, CA 94588. The petition requested that

40 CFR 180.940(a) be amended by establishing exemptions from the
requirement of a tolerance for residues of (E)-2-Hexen-1-yl acetate
(CAS Reg. No. 2497-18-9); 1,3-Nonanediol acetate (mixed esters) (CAS
Reg. No. 1322-17-4); 10-Undecenal (CAS Reg. No. 112-45-8); 10-
Undecenoic acid (CAS Reg. No. 112-38-9); 10-Undecenoic acid, ethyl
ester (CAS Reg. No. 692-86-4); 1H-3a,7-Methanoazulen-6-ol, octahydro-
3,6,8,8-tetramethyl-,[3R-
(3.[alpha],3a.[beta],6.[alpha],7.[beta],8a[alpha])] (CAS Reg. No. 77-
53-2); 1-Hexanol, 3,5,5-trimethyl- (CAS Reg. No. 3452-97-9); 1-pentanol
(CAS Reg. No. 71-41-0); 2,4-Hexadienyl isobutyrate (CAS Reg. No. 16491-
24-0); 2,5,7-Octatrien-1-ol, 2,6-dimethyl0, 1-acetate (CAS Reg. No.
197098-61-6); 2,6,6-Trimethyl-1&2-cyclohexen-1-carboxaldehyde (CAS Reg.
No. 432-25-7); 2,6,6-Trimethyl-1-cyclohexen-1-acetaldehyde (CAS Reg.
No. 472-66-2); 2,6-Nonadien-1-ol (CAS Reg. No. 7786-44-9); 2,6-
Nonadienal diethyl acetal (CAS Reg. No. 67674-36-6); 2-Cyclohexylethyl
acetate (CAS Reg. No. 21722-83-8); 2-Dodecenal (CAS Reg. No. 4826-62-
4); 2-Formyl-6,6-dimethylbicyclo(3.1.1)hept-2-ene (CAS Reg. No. 564-94-
3); 2-Hexen-1-ol (CAS Reg. No. 2305-21-7); 2-Methyl butyl acetate (CAS
Reg. No. 624-41-9); 2-Methylbutyric acid (CAS Reg. No. 116-53-0); 2-
Methyloctanal (CAS Reg. No. 7786-29-0); 2-Methylpent-2-en-1-oic acid
(CAS Reg. No. 3142-72-1); 2-Methyl-trans-2-butenoic acid (CAS Reg. No.
80-59-1); 2-Nonenal (CAS Reg. No. 2463-53-8); 3,7-Dimethyl-1-octanol
(CAS Reg. No. 106-21-8); 3,7-Dimethyl-6-octen-1-ol (CAS Reg. No. 106-
22-9); 3,7-Dimethyl-6-octenoic acid (CAS Reg. No. 502-47-6); 3-Hexen-1-
ol, (3Z)- (CAS Reg. No. 928-96-1); 3-Hexen-1-ol, acetate, (3Z)- (CAS
Reg. No. 3681-71-8); 3-hexenyl 2-methylbutanoate (CAS Reg. No. 10094-
41-4); 3-Hexenyl formate (CAS Reg. No. 2315-09-5); 3-Methyl-2-buten-1-
ol (CAS Reg. No. 556-82-1); 3-Methylbutyraldehyde (CAS Reg. No. 590-86-
3); 3-Methylcrotonic acid (CAS Reg. No. 541-47-9); 4-Carvomenthenol
(CAS Reg. No. 562-74-3); 4-Decenal (CAS Reg. No. 30390-50-2); 5-Octen-
1-ol, (5Z)- (CAS Reg. No. 64275-73-6); 9-Decenal (CAS Reg. No. 39770-
05-3); 9-Undecenal (CAS Reg. No. 143-14-6); Acetal (CAS Reg. No. 105-
57-7); Acetic acid, octyl ester (CAS Reg. No. 112-14-1); Amyl butyrate
(CAS Reg. No. 540-18-1); Amyl formate (CAS Reg. No. 638-49-3); Amyl
hexanoate (CAS Reg. No. 540-07-8); Bois de rose oil (CAS Reg. No. 8015-
77-8); Butanoic acid, 3-methyl-, 2-methylpropyl ester (CAS Reg. No.
589-59-3); Butyl 10-undecenoate (CAS Reg. No. 109-42-2); Butyl acetate
(CAS Reg. No. 123-86-4); Butyl butyrate (CAS Reg. No. 109-21-7); Butyl
butyryllactate (CAS Reg. No. 7492-70-8); Butyl isovalerate (CAS Reg.
No. 109-19-3); Chamomile flower, Roman, oil (Anthemis nobilis L.) (CAS
Reg. No. 8015-92-7); cis-3-Hexenyl isobutyrate (CAS Reg. No. 41519-23-
7); cis-3-Hexenyl propionate (CAS Reg. No. 33467-74-2); cis-3-Hexenyl
tiglate (CAS Reg. No. 67883-79-8); cis-[alpha]-Santalol (CAS Reg. No.
115-71-9); cis-[beta]-Santalol (CAS Reg. No. 77-42-9); Citral (CAS Reg.
No. 5392-40-5); Citral dimethyl acetal (CAS Reg. No. 7549-37-3);
Citronellal (CAS Reg. No. 106-23-0); Citronelloxyacetaldehyde (CAS Reg.
No. 7492-67-3); Citronellyl butyrate (CAS Reg. No. 141-16-2);
Citronellyl formate (CAS Reg. No. 105-85-1); Citronellyl isobutyrate
(CAS Reg. No. 97-89-2); Citronellyl propionate (CAS Reg. No. 141-14-0);
Citronellyl tiglate (CAS Reg. No. 24717-85-9); Clary oil (Salvia
sclarea L.) (CAS Reg. No. 8016-63-5); Cognac oil, green (CAS Reg. No.
8016-21-5); Coriander oil (Coriandrum sativum L.) (CAS Reg. No. 8008-
52-4); Decanoic acid, 4-hydroxy-4-methyl-,[gamma].-lactone (CAS Reg.
No. 7011-83-8); Decyl acetate (CAS Reg. No. 112-17-4); Diethyl sebacate
(CAS Reg. No. 110-40-7); Diethyl tartrate (CAS Reg. No. 87-91-2);
Dimethylcyclohex-3-ene-1-carbaldehyde (CAS Reg. No. 27939-60-2); DL-
Tartaric acid (CAS Reg. No. 133-37-9); Ethyl 2-hexylacetoacetate (CAS
Reg. No. 29214-60-6); Ethyl 2-methyl-3-pentenoate (CAS Reg. No. 1617-
23-8); Ethyl 2-methylbutyrate (CAS Reg. No. 7452-79-1); Ethyl 2-
methylpentanoate (CAS Reg. No. 39255-32-8); Ethyl 3-hydroxybutyrate
(CAS Reg. No. 5405-41-4); Ethyl formate (CAS Reg. No. 109-94-4); Ethyl
isovalerate (CAS Reg. No. 108-64-5); ethyl lactate (CAS Reg. No. 97-64-
3); Ethyl levulinate (CAS Reg. No. 539-88-8); Ethyl propionate (CAS
Reg. No. 105-37-3); Ethyl tiglate (CAS Reg. No. 5837-78-5); Farnesol
(CAS Reg. No. 4602-84-0); Farnesyl acetate (CAS Reg. No. 29548-30-9);
gamma-Valerolactone (CAS Reg. No. 108-29-2); Geranic acid (CAS Reg. No.
459-80-3); Geraniol (CAS Reg. No. 106-24-1); Geranyl butyrate (CAS Reg.
No. 106-29-6); Geranyl formate (CAS Reg. No. 105-86-2); Geranyl
isobutyrate (CAS Reg. No. 2345-26-8); Geranyl propionate (CAS Reg. No.
105-90-8); Geranyl tiglate (CAS Reg. No. 7785-33-3); Helichrysum leaf
oil (Helichrysum angustifolium) (CAS Reg. No. 8023-95-8); Heptyl
acetate (CAS Reg. No. 112-06-1); Hexadecanoic acid (CAS Reg. No. 57-10-
3); Hexadecanoic acid, ethyl ester (CAS Reg. No. 628-97-7); Hexyl 2-
methylbutanoate (CAS Reg. No. 10032-15-2); Hexyl octanoate (CAS Reg.
No. 1117-55-1); Hydroxycitronellal dimethyl acetal (CAS Reg. No. 141-
92-4); Hyssop oil (Hyssopus officinalis L.) (CAS Reg. No. 8006-83-5);
Isoamyl acetate (CAS Reg. No. 123-92-2); Isoamyl alcohol (CAS Reg. No.
123-51-3); Isoamyl isovalerate (CAS Reg. No. 659-70-1); Isoamyl
propionate (CAS Reg. No. 105-68-0); Isobutyl 2-butenoate (CAS Reg. No.
589-66-2); Isobutyl angelate (CAS Reg. No. 7779-81-9); Isobutyl
butyrate (CAS Reg. No. 539-90-2); Isobutyraldehyde (CAS Reg. No. 78-84-
2); Isobutyric acid (CAS Reg. No. 79-31-2); Isovaleric acid (CAS Reg.
No. 503-74-2); Jasmine lactone (CAS Reg. No. 25524-95-2); laevo-Bornyl
acetate (CAS Reg. No. 5655-61-8); Lauryl acetate (CAS Reg. No. 112-66-
3); Levulinic acid (CAS Reg. No. 123-76-2); Linalool (CAS Reg. No. 78-
70-6); Linalool acetate (CAS Reg. No. 115-95-7); Linalyl formate (CAS
Reg. No. 115-99-1); Linalyl hexanoate (CAS Reg. No. 7779-23-9); Linalyl
isobutyrate (CAS Reg. No. 78-35-3); Linalyl isovalerate (CAS Reg. No.
1118-27-0); Linalyl propionate (CAS Reg. No. 144-39-8); Linoleic acid
(CAS Reg. No. 60-33-3); Linoleic acid, methyl ester (CAS Reg. No. 112-
63-0); Lovage oil (Levisticum officinale Koch) (CAS Reg. No. 8016-31-
7); Methyl 2-methylbutyrate (CAS Reg. No. 868-57-5); Methyl 3,7-
dimethyl-6-octenoate (CAS Reg. No. 2270-60-2); Methyl 3-nonenoate (CAS
Reg. No. 13481-87-3); Methyl butyrate (CAS Reg. No. 623-42-7); Methyl
hexanoate (CAS Reg. No. 106-70-7); Methyl linolenate (CAS Reg. No. 301-
00-8); Methyl octanoate (CAS Reg. No. 111-11-5); Methyl tetradecanoate
(CAS Reg. No. 124-10-7); Methyl undec-10-enoate (CAS Reg. No. 111-81-
9); Musk ambrette (CAS Reg. No. 123-69-3); n-Butyl 2-methylbutyrate
(CAS Reg. No. 15706-73-7); Nerolidiol (CAS Reg. No. 142-50-7); Neryl
acetate (CAS Reg. No. 141-12-8); Neryl formate (CAS Reg. No. 2142-94-
1); Nonyl acetate (CAS Reg. No. 143-13-5); Octadecanoic acid (CAS Reg.
No. 57-11-4); Oil of citronella (CAS Reg. No. 8000-29-1); Oils,
geranium (CAS Reg. No. 8000-46-2); Oils, lavender (CAS Reg. No. 8000-
28-0); Oils, lemon, terpene-free (CAS Reg. No. 68648-39-5); Oils,
palmarosa (CAS Reg. No. 8014-19-5); Oleic acid (CAS Reg. No. 112-80-1);
Oleic acid, ethyl ester (CAS Reg. No. 111-62-6); Oleyl alcohol (CAS
Reg. No. 143-28-2); Orange flower water absolute (CAS Reg. No. 8030-28-
2); Oxacycloheptadec-10-ene-2-one (CAS Reg. No. 28645-51-4); p-
[alpha],[alpha]-Trimethylbenzyl alcohol (CAS Reg. No. 1197-01-9);
Petitgrain Paraguay oil (CAS Reg. No. 8016-44-2

(NEW CAS Reg. No. 8014-17-3); p-Mentha-1,8-dien-7-ol (CAS Reg. No. 536-
59-4); p-Mentha-1,8-dien-7-yl acetate (CAS Reg. No. 15111-96-3);
Propanoic acid (CAS Reg. No. 79-09-4); Propylene glycol (CAS Reg. No.
57-55-6); Pyruvic acid (CAS Reg. No. 127-17-3); Sandalwood yellow oil
(Santalum album L.) (CAS Reg. No. 8006-87-9); Santalol (CAS Reg. No.
11031-45-1); Sclareol (CAS Reg. No. 515-03-7); Spike lavender oil
(Lavandula spp.) (CAS Reg. No. 8016-78-2); Tartaric acid (CAS Reg. No.
87-69-4); Terpinyl acetate (Isomer mixture) (CAS Reg. No. 8007-35-0);
Tetradecanoic acid, ethyl ester (CAS Reg. No. 124-06-1);
Tetrahydrogeranial (CAS Reg. No. 5988-91-0); trans-3-Heptenyl 2-
methylpropanoate (CAS Reg. No. 67801-45-0); Violet leaves absolute
(Viola odorata L.) (CAS Reg. No. 90147-36-7); [alpha],[alpha]-
Dimethylphenethyl alcohol (CAS Reg. No. 100-86-7); [alpha]-Terpinyl
propionate (CAS Reg. No. 80-27-3); [gamma]-Butyrolactone (CAS Reg. No.
96-48-0); [gamma]-Dodecalactone (CAS Reg. No. 2305-05-7); [delta]-
Dodecalactone (CAS Reg. No. 713-95-1); [delta]-Octalactone (CAS Reg.
No. 698-76-0); [egr]-Decalactone (CAS Reg. No. 5579-78-2); [omega]-6-
Hexadecenlactone (CAS Reg. No. 7779-50-2); when used as inert
ingredients (fragrance components) in pesticide formulations applied to
food contact surfaces in public eating places, dairy-processing
equipment, and food-processing equipment with end-use concentrations
not to exceed 100 ppm. That document referenced a summary of the
petition prepared by Innovative Reform Group on behalf of The Clorox
Company, which is available in the docket, https://www.regulations.gov.
There were no comments received in response to the notice of filing.

III. Inert Ingredient Definition

    Inert ingredients are all ingredients that are not active
ingredients as defined in 40 CFR 153.125 and include, but are not
limited to, the following types of ingredients (except when they have a
pesticidal efficacy of their own): solvents such as alcohols and
hydrocarbons; surfactants such as polyoxyethylene polymers and fatty
acids; carriers such as clay and diatomaceous earth; thickeners such as
carrageenan and modified cellulose; wetting, spreading, and dispersing
agents; propellants in aerosol dispensers; microencapsulating agents;
and emulsifiers. The term ``inert'' is not intended to imply
nontoxicity; the ingredient may or may not be chemically active.
Generally, EPA has exempted inert ingredients from the requirement of a
tolerance based on the low toxicity of the individual inert
ingredients.

IV. Aggregate Risk Assessment and Determination of Safety

    Section 408(c)(2)(A)(i) of FFDCA allows EPA to establish an
exemption from the requirement for a tolerance (the legal limit for a
pesticide chemical residue in or on a food) only if EPA determines that
the tolerance is ``safe.'' Section 408(c)(2)(A)(ii) of FFDCA defines
``safe'' to mean that ``there is a reasonable certainty that no harm
will result from aggregate exposure to the pesticide chemical residue,
including all anticipated dietary exposures and all other exposures for
which there is reliable information.'' This includes exposure through
drinking water and in residential settings but does not include
occupational exposure. When making a safety determination for an
exemption for the requirement of a tolerance, FFDCA section
408(c)(2)(B) directs EPA to consider the considerations in section
408(b)(2)(C) and (D). Section 408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure of infants and children to the
pesticide chemical residue in establishing a tolerance and to ``ensure
that there is a reasonable certainty that no harm will result to
infants and children from aggregate exposure to the pesticide chemical
residue. . . .'' Section 408(b)(2)(D) lists other factors for EPA's
consideration in making safety determinations, e.g., the validity,
completeness, and reliability of available data, nature of toxic
effects, available information concerning the cumulative effects of the
pesticide chemical and other substances with a common mechanism of
toxicity, and available information concerning aggregate exposure
levels to the pesticide chemical and other related substances, among
other factors.
    EPA establishes exemptions from the requirement of a tolerance only
in those cases where it can be clearly demonstrated that the risks from
aggregate exposure to pesticide chemical residues under reasonably
foreseeable circumstances will pose no harm to human health. In order
to determine the risks from aggregate exposure to pesticide inert
ingredients, the Agency considers the toxicity of the inert in
conjunction with possible exposure to residues of the inert ingredient
through food, drinking water, and through other exposures that occur as
a result of pesticide use in residential settings. If EPA is able to
determine that a finite tolerance is not necessary to ensure that there
is a reasonable certainty that no harm will result from aggregate
exposure to the inert ingredient, an exemption from the requirement of
a tolerance may be established.
    Consistent with FFDCA section 408(c)(2)(A), and the factors
specified in FFDCA section 408(c)(2)(B), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for the various fragrance
components identified in Unit II of this document, including exposure
resulting from the exemptions established by this action. EPA's
assessment of exposures and risks associated with these various
fragrance components follows.

A. Toxicological Profile

    EPA has evaluated the available toxicity data and considered their
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children. Specific information on the studies received and the nature
of the adverse effects caused by the various fragrance components
identified in Unit II, as well as the no-observed-adverse-effect-level
(NOAEL) and the lowest-observed-adverse-effect-level (LOAEL) from the
toxicity studies, are discussed in this unit.
    The Agency assessed these fragrance components via the Threshold of
Toxicological Concern (TTC) approach as outlined by the European Food
Safety Authority (EFSA) in their 2019 guidance document on the use of
TTC in food safety assessment. Information regarding the database of
studies and chemicals used to derive TTCs are reviewed therein. The TTC
approach has been used by the Joint Expert Committee on Food Additives
of the United Nations' (U.N.) Food and Agriculture Organization and the
World Health Organization (JECFA), the former Scientific Committee on
Food of the European Commission, the European Medicines Agency, and
EFSA.
    Information from JECFA reports as well as predictive toxicology
using the Organisation for Economic Co-operation and Development (OECD)
Quantitative Structure-Activity Relationships (QSAR) Toolbox was used
to confirm that the fragrances listed in Unit II have low carcinogenic
potential and are thus good candidates for the application of the TTC
method. Although 27 chemicals had in silico carcinogenicity alerts,

JECFA concluded and EPA concurs that all fragrances listed in Unit II
have low carcinogenic potential, based on in vitro and/or in vivo
genotoxicity studies available on the chemical or structurally related
chemicals. Therefore, the TTC method can be applied to these
fragrances.
    TTCs are derived from a conservative and rigorous approach to
establish generic threshold values for human exposure at which a very
low probability of adverse effects is likely. By comparing a range of
compounds by Cramer Class (classes I, II, and III which correspond to
the probability of low, moderate and high toxicity) and NOEL (no-
observed-effect-level), fifth percentile NOELs were established for
each Cramer Class as ``Human Exposure Thresholds''. These values were
3, 0.91 and 0.15 mg/kg/day for classes I, II, and III, respectively.

B. Toxicological Points of Departure/Levels of Concern

    Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which no adverse effects are observed (the NOAEL)
and the lowest dose at which adverse effects of concern are identified
(the LOAEL). Uncertainty/safety factors are used in conjunction with
the POD to calculate a safe exposure level--generally referred to as a
population-adjusted dose (PAD) or a reference dose (RfD)--and a safe
margin of exposure (MOE). For non-threshold risks, the Agency assumes
that any amount of exposure will lead to some degree of risk. Thus, the
Agency estimates risk in terms of the probability of an occurrence of
the adverse effect expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/overview-risk-assessment-pesticide-program.
    The human exposure threshold value for threshold (i.e., non-cancer)
risks is based upon Cramer structural class. All of the fragrance
components listed in Unit II are in Cramer Class I, which is defined as
chemicals of simple structure and efficient modes of metabolism,
suggesting low oral toxicity. Therefore, the NOEL of 3 mg/kg/day is
selected as the point of departure for all exposure scenarios assessed
(chronic dietary, incidental oral, dermal and inhalation exposures).

C. Exposure Assessment

    1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to the fragrance components listed in Unit II (e.g., ingesting
foods that come in contact with surfaces treated with pesticide
formulations containing these fragrance components, and drinking water
exposures), EPA considered exposure under the proposed exemptions from
the requirement of a tolerance.
    The dietary assessment for food contact sanitizer solutions
calculated the Daily Dietary Dose (DDD) and the Estimated Daily Intake
(EDI). The assessment considered application rates, residual solution
or quantity of solution remaining on the treated surface without
rinsing with potable water, surface area of the treated surface which
comes into contact with food, pesticide migration fraction, and body
weight. These assumptions are based on U.S. Food and Drug
Administration guidelines.
    2. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., textiles (clothing and diapers), carpets, swimming
pools, and hard surface disinfection on walls, floors, tables).
    The fragrance components listed in Unit II may be used as inert
ingredients in products that are registered for specific uses that may
result in residential exposure, such as pesticides used in and around
the home. The Agency conducted a conservative assessment of potential
residential exposure by assessing various fragrance components in
disinfectant-type uses (indoor scenarios). The Agency's assessment of
adult residential exposure combines high-end dermal and inhalation
handler exposure from indoor hard surface, wiping, and aerosol spray
uses. The Agency's assessment of children's residential exposure
includes total post-application exposures associated with contact with
treated indoor surfaces (dermal and hand-to-mouth exposures).
    3. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
    Based on the lack of toxicity in the available database, EPA has
not found the fragrance components listed in Unit II to share a common
mechanism of toxicity with any other substances, nor do they appear to
produce a toxic metabolite produced by other substances. For the
purposes of the tolerance exemptions established in this rule,
therefore, EPA has assumed that the fragrance components listed in Unit
II do not have common mechanisms of toxicity with other substances. For
information regarding EPA's efforts to determine which chemicals have a
common mechanism of toxicity and to evaluate the cumulative effects of
such chemicals, see EPA's website at https://www.epa.gov/pesticide-science-and-assessing-pesticide-risks/cumulative-assessment-risk-pesticides.

D. Additional Safety Factor for the Protection of Infants and Children

    Section 408(b)(2)(C) of FFDCA provides that EPA shall apply an
additional tenfold (10X) margin of safety for infants and children in
the case of threshold effects to account for prenatal and postnatal
toxicity and the completeness of the database on toxicity and exposure
unless EPA determines based on reliable data that a different margin of
safety will be safe for infants and children. This additional margin of
safety is commonly referred to as the Food Quality Protection Act
(FQPA) Safety Factor (SF). In applying this provision, EPA either
retains the default value of 10X, or uses a different additional safety
factor when reliable data available to EPA support the choice of a
different factor.
    The FQPA SF has been reduced to 1X in this risk assessment because
clear NOELs and LOELs were established in the studies used to derive
the endpoints (which included developmental and reproductive toxicity
studies), maternal and developmental-specific 5th percentile NOELs
indicate low potential for offspring susceptibility, and the
conservative assumptions made in the exposure assessment are unlikely
to underestimate risk.

E. Aggregate Risks and Determination of Safety

    EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing aggregate exposure estimates to the
acute PAD (aPAD) and chronic PAD (cPAD). For linear cancer risks, EPA
calculates the lifetime probability of acquiring cancer given the

estimated aggregate exposure. Short-, intermediate-, and chronic-term
risks are evaluated by comparing the estimated aggregate food, water,
and residential exposure to the appropriate PODs to ensure that an
adequate MOE exists.
    1. Acute aggregate risk. An acute aggregate risk assessment takes
into account acute exposure estimates from dietary consumption of food
and drinking water. No adverse effects resulting from a single oral
exposure were identified and no acute dietary endpoint was selected for
any of the fragrance components listed in Unit II. Therefore, these
fragrance components are not expected to pose an acute risk.
    2. Short-term aggregate risk. Short-term aggregate exposure takes
into account short-term residential exposure plus chronic exposure to
food and water (considered to be a background exposure level). For
residential handler short-term exposure scenarios, MOEs ranged from 140
to 2,500, while for residential post-application exposure scenarios,
MOEs ranged from 380 to 7,400. These MOEs are greater than the level of
concern (LOC) of 100 and therefore are not of concern. The short-term
aggregate MOE is 109 for adults and 135 for children, which are greater
than the LOC of 100 and therefore are not of concern.
    3. Intermediate-term risk. Intermediate-term aggregate exposure
takes into account intermediate-term residential exposure plus chronic
exposure to food and water (considered to be a background exposure
level). An intermediate-term adverse effect was identified; however,
the fragrance components listed in Unit II are not currently used as an
inert ingredient in pesticide products that are registered for any use
patterns that would result in intermediate-term residential exposure.
Because there is no intermediate-term residential exposure and chronic
dietary exposure has already been assessed under the appropriately
protective cPAD (which is at least as protective as the POD used to
assess intermediate-term risk), no further assessment of intermediate-
term risk is necessary, and EPA relies on the chronic dietary risk
assessment for evaluating intermediate-term risk for these fragrance
components.
    4. Chronic aggregate risk. Using the exposure assumptions described
in this unit for chronic exposure, EPA has concluded that chronic
exposure to the fragrance components listed in Unit II from food and
water will utilize 19% of the cPAD for the U.S. population and 48% of
the cPAD for children 1 to 2 years old, the population group receiving
the greatest exposure. Chronic residential exposure to residues of
these fragrance components is not expected. Therefore, the chronic
aggregate risk is equal to the chronic dietary exposure for children 1
t o2 years old (48% of the PAD).
    5. Aggregate cancer risk for U.S. population. There is low concern
for genotoxicity/carcinogenicity in humans for the fragrance components
listed in Unit II of this document. Therefore, the assessment under the
TTC value for non-cancer risks is protective for all risks, including
carcinogenicity.
    6. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children, from aggregate
exposure to residues of the fragrance components listed in Unit II.

V. Other Considerations

Analytical Enforcement Methodology

    An analytical method is not required for enforcement purposes since
the Agency is not establishing a numerical tolerance for residues of
the fragrance components listed in Unit II of this document in or on
any food commodities. EPA is establishing limitations on the amount of
these fragrance components that may be used in antimicrobial pesticide
formulations. These limitations will be enforced through the pesticide
registration process under the Federal Insecticide, Fungicide, and
Rodenticide Act (``FIFRA''), 7 U.S.C. 136 et seq. EPA will not register
any pesticide formulation for food use that contains these fragrance
components in excess of 100 ppm in the final pesticide formulation.

VI. Conclusions

    Therefore, exemptions from the requirement of a tolerance are
established for residues of the various fragrance components listed in
Unit II of this document when used as inert ingredients (fragrance
components) in pesticide formulations applied to food-contact surfaces
in public eating places, dairy-processing equipment, and food-
processing equipment and utensils with an end-use concentration not to
exceed 100 ppm under 40 CFR 180.940(a).

VII. Statutory and Executive Order Reviews

    This action establishes exemptions from the requirement of a
tolerance under FFDCA section 408(d) in response to a petition
submitted to the Agency. The Office of Management and Budget (OMB) has
exempted these types of actions from review under Executive Order
12866, entitled ``Regulatory Planning and Review'' (58 FR 51735,
October 4, 1993). Because this action has been exempted from review
under Executive Order 12866, this action is not subject to Executive
Order 13211, entitled ``Actions Concerning Regulations That
Significantly Affect Energy Supply, Distribution, or Use'' (66 FR
28355, May 22, 2001), or Executive Order 13045, entitled ``Protection
of Children from Environmental Health Risks and Safety Risks'' (62 FR
19885, April 23, 1997). This action does not contain any information
collections subject to OMB approval under the Paperwork Reduction Act
(PRA) (44 U.S.C. 3501 et seq.), nor does it require any special
considerations under Executive Order 12898, entitled ``Federal Actions
to Address Environmental Justice in Minority Populations and Low-Income
Populations'' (59 FR 7629, February 16, 1994).
    Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the exemptions in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
    This action directly regulates growers, food processors, food
handlers, and food retailers, not States or Tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
Tribal governments, on the relationship between the National Government
and the States or Tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian Tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999), and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000), do not apply to this action. In addition,
this action does not impose any enforceable duty or contain any
unfunded mandate as described under Title II of the Unfunded Mandates
Reform Act (UMRA) (2 U.S.C. 1501 et seq.).
    This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section

12(d) of the National Technology Transfer and Advancement Act (NTTAA)
(15 U.S.C. 272 note).

VIII. Congressional Review Act

    Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).

List of Subjects in 40 CFR Part 180

    Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.

    Dated: February 17, 2023.
Daniel Rosenblatt,
Acting Director, Registration Division, Office of Pesticide Programs.

    Therefore, for the reasons stated in the preamble, EPA is amending
40 CFR chapter I as follows:

PART 180--TOLERANCES AND EXEMPTIONS FOR PESTICIDE CHEMICAL RESIDUES
IN FOOD

0
1. The authority citation for part 180 continues to read as follows:

    Authority:  21 U.S.C. 321(q), 346a and 371.

0
2. Section 180.940 is amended by adding in alphabetical order the
following inert ingredients to table 1 to paragraph (a):
0
a. Acetal.
0
b. Acetic acid, octyl ester.
0
c. Amyl butyrate.
0
d. Amyl formate.
0
e. Amyl hexanoate.
0
f. Bois de rose oil.
0
g. Butanoic acid, 3-methyl-, 2-methylpropyl ester.
0
h. Butyl acetate.
0
i. Butyl butyrate.
0
j. Butyl butyryllactate.
0
k. Butyl isovalerate.
0
l. n-Butyl 2-methylbutyrate.
0
m. Butyl 10-undecenoate.
0
n. [gamma]-Butyrolactone.
0
o. 4-Carvomenthenol.
0
p. Chamomile flower, Roman, oil (Anthemis nobilis L.).
0
q. Citral dimethyl acetal.
0
r. Citronellal.
0
s. Citronelloxyacetaldehyde.
0
t. Citronellyl butyrate.
0
u. Citronellyl formate.
0
v. Citronellyl isobutyrate.
0
w. Citronellyl propionate.
0
x. Citronellyl tiglate.
0
y. Clary oil (Salvia sclarea L.).
0
z. Cognac oil, green.
0
aa. Coriander oil (Coriandrum sativum L.).
0
bb. 2-Cyclohexylethyl acetate.
0
cc. [egr]-Decalactone.
0
dd. Decanoic acid, 4-hydroxy-4-methyl-[gamma]-lactone.
0
ee. 4-Decenal.
0
ff. 9-Decenal.
0
gg. Decyl acetate.
0
hh. Diethyl sebacate.
0
ii. Diethyl tartrate.
0
jj. 3,7-Dimethyl-6-octenoic acid.
0
kk. Dimethylcyclohex-3-ene-1-carbaldehyde.
0
ll. [alpha],[alpha]-Dimethylphenethyl alcohol.
0
mm. [gamma]-Dodecalactone.
0
nn. [delta]-Dodecalactone.
0
oo. 2-Dodecenal.
0
pp. Ethyl formate.
0
qq. Ethyl 2-hexylacetoacetate.
0
rr. Ethyl 3-hydroxybutyrate.
0
ss. Ethyl isovalerate.
0
tt. Ethyl levulinate.
0
uu. Ethyl 2-methyl-3-pentenoate.
0
vv. Ethyl 2-methylpentanoate.
0
ww. Ethyl propionate.
0
xx. Ethyl tiglate.
0
yy. Farnesol.
0
zz. Farnesyl acetate.
0
aaa. 2-Formyl-6,6-dimethylbicyclo(3.1.1)hept-2-ene.
0
bbb. Geranic acid.
0
ccc. Geraniol.
0
ddd. Geranyl butyrate.
0
eee. Geranyl formate.
0
fff. Geranyl isobutyrate.
0
ggg. Geranyl propionate.
0
hhh. Geranyl tiglate.
0
iii. Helichrysum leaf oil (Helichrysum angustifolium).
0
jjj. trans-3-Heptenyl 2-methylpropanoate.
0
kkk. Heptyl acetate.
0
lll. Hexadecanoic acid.
0
mmm. Hexadecanoic acid, ethyl ester.
0
nnn. [omega]-6-Hexadecenlactone.
0
ooo. 2,4-Hexadienyl isobutyrate.
0
ppp. 1-Hexanol, 3,5,5-trimethyl-.
0
qqq. 2-Hexen-1-ol.
0
rrr. 3-Hexen-1-ol, (3Z)-.
0
sss. (E)-2-Hexen-1-yl acetate.
0
ttt. cis-3-Hexenyl isobutyrate.
0
uuu. cis-3-Hexenyl propionate.
0
vvv. cis-3-Hexenyl tiglate.
0
www. 3-Hexenyl formate.
0
xxx. Hexyl 2-methylbutanoate.
0
yyy. Hexyl octanoate.
0
zzz. Hydroxycitronellal dimethyl acetal.
0
aaaa. Hyssop oil (Hyssopus officinalis L.).
0
bbbb. Isoamyl isovalerate.
0
cccc. Isoamyl propionate.
0
dddd. Isobutyl angelate.
0
eeee. Isobutyl 2-butenoate.
0
ffff. Isobutyl butyrate.
0
gggg. Isobutyraldehyde.
0
hhhh. Isobutyric acid.
0
iiii. Isovaleric acid.
0
jjjj. Jasmine lactone.
0
kkkk. laevo-Bornyl acetate.
0
llll. Lauryl acetate.
0
mmmm. Levulinic acid.
0
nnnn. Linalool acetate.
0
oooo. Linalyl formate.
0
pppp. Linalyl hexanoate.
0
qqqq. Linalyl isobutyrate.
0
rrrr. Linalyl isovalerate.
0
ssss. Linalyl propionate.
0
tttt. Linoleic acid, methyl ester.
0
uuuu. Lovage oil (Levisticum officinale Koch).
0
vvvv. p-Mentha-1,8-dien-7-ol.
0
wwww. p-Mentha-1,8-dien-7-yl acetate.
0
xxxx. 1H-3a,7-Methanoazulen-6-ol, octahydro-3,6,8,8-tetramethyl-,[3R-
(3.[alpha],3a.[beta],6.[alpha],7.[beta],8a[alpha])].
0
yyyy. 3-Methyl-2-buten-1-ol.
0
zzzz. 2-Methyl butyl acetate.
0
aaaaa. 3-Methylbutyraldehyde
0
bbbbb. Methyl butyrate.
0
ccccc. 2-Methylbutyric acid.
0
ddddd. 3-Methylcrotonic acid.
0
eeeee. Methyl 3,7-dimethyl-6-octenoate.
0
fffff. Methyl hexanoate.
0
ggggg. Methyl linolenate.
0
hhhhh. Methyl 2-methylbutyrate.
0
iiiii. Methyl 3-nonenoate.
0
jjjjj. 2-Methyloctanal.
0
kkkkk. Methyl octanoate.
0
lllll. 2-Methylpent-2-en-1-oic acid.
0
mmmmm. Methyl tetradecanoate.
0
nnnnn. 2-Methyl-trans-2-butenoic acid.
0
ooooo. Methyl undec-10-enoate.
0
ppppp. Musk ambrette.
0
qqqqq. Nerolidiol.
0
rrrrr. Neryl formate.
0
sssss. 2,6-Nonadien-1-ol.
0
ttttt. 2,6-Nonadienal diethyl acetal.
0
uuuuu. 1,3-Nonanediol acetate (mixed esters).
0
vvvvv. 2-Nonenal.
0
wwwww. Nonyl acetate.
0
xxxxx. Octadecanoic acid.
0
yyyyy. [delta]-Octalactone.
0
zzzzz. 2,5,7-Octatrien-1-ol, 2,6-dimethyl0, 1-acetate.
0
aaaaaa. 5-Octen-1-ol, (5Z)-.
0
bbbbbb. Oil of citronella.
0
cccccc. Oils, geranium.
0
dddddd. Oils, lavender.
0
eeeeee. Oils, lemon, terpene-free.
0
ffffff. Oils, palmarosa.
0
gggggg. Oleic acid.
0
hhhhhh. Oleic acid, ethyl ester.
0
iiiiii. Oleyl alcohol.
0
jjjjjj. Orange flower water absolute.
0
kkkkkk. Oxacycloheptadec-10-ene-2-one.
0
llllll. 1-pentanol.
0
mmmmmm. Petitgrain Paraguay oil.
0
nnnnnn. Propanoic acid.
0
oooooo. Pyruvic acid.
0
pppppp. Sandalwood yellow oil (Santalum album L.).

0
qqqqqq. Santalol.
0
rrrrrr. cis-[alpha]-Santalol.
0
ssssss. cis-[beta]-Santalol.
0
tttttt. Sclareol.
0
uuuuuu. Spike lavender oil (Lavandula spp.).
0
vvvvvv. Tartaric acid.
0
wwwwww. DL-Tartaric acid.
0
xxxxxx. [alpha]-Terpinyl propionate.
0
yyyyyy. Tetradecanoic acid, ethyl ester.
0
zzzzzz. Tetrahydrogeranial.
0
aaaaaaa. 2,6,6-Trimethyl-1-cyclohexen-1-acetaldehyde.
0
bbbbbbb. 2,6,6-Trimethyl-1&2-cyclohexen-1-carboxaldehyde.
0
ccccccc. p-[alpha],[alpha]-Trimethylbenzyl alcohol.
0
ddddddd. 9-Undecenal.
0
eeeeeee. 10-Undecenal.
0
fffffff. 10-Undecenoic acid.
0
ggggggg. 10-Undecenoic acid, ethyl ester.
0
hhhhhhh. [gamma]-Valerolactone.
0
ppppppp. Violet leaves absolute (Viola odorata L.).
    The additions read as follows:

Sec.  180.940  Tolerance exemptions for active and inert ingredients
for use in antimicrobial formulations (Food-contact surface sanitizing
solutions).

* * * * *
    (a) * * *

                        Table 1 to Paragraph (a)
------------------------------------------------------------------------
      Pesticide chemical        CAS Reg. No.             Limits
------------------------------------------------------------------------

                              * * * * * * *
Acetal.......................        105-57-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Acetic acid, octyl ester.....        112-14-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Amyl butyrate................        540-18-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Amyl formate.................        638-49-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Amyl hexanoate...............        540-07-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Bois de rose oil.............       8015-77-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Butanoic acid, 3-methyl-, 2-         589-59-3  When ready for use, the
 methylpropyl ester.                            end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Butyl acetate................        123-86-4  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Butyl butyrate...............        109-21-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Butyl butyryllactate.........       7492-70-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Butyl isovalerate............        109-19-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
n-Butyl 2-methylbutyrate.....      15706-73-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Butyl 10-undecenoate.........        109-42-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
[gamma]-Butyrolactone........         96-48-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
4-Carvomenthenol.............        562-74-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Chamomile flower, Roman, oil        8015-92-7  When ready for use, the
 (Anthemis nobilis L.).                         end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Citral dimethyl acetal.......       7549-37-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Citronellal..................        106-23-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Citronelloxyacetaldehyde.....       7492-67-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Citronellyl butyrate.........        141-16-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Citronellyl formate..........        105-85-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Citronellyl isobutyrate......         97-89-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Citronellyl propionate.......        141-14-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Citronellyl tiglate..........      24717-85-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Clary oil (Salvia sclarea L.)       8016-63-5  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Cognac oil, green............       8016-21-5  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Coriander oil (Coriandrum           8008-52-4  When ready for use, the
 sativum L.).                                   end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
2-Cyclohexylethyl acetate....      21722-83-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
[egr]-Decalactone............       5579-78-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Decanoic acid, 4-hydroxy-4-         7011-83-8  When ready for use, the
 methyl-[gamma]-lactone.                        end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
4-Decenal....................      30390-50-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
9-Decenal....................      39770-05-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Decyl acetate................        112-17-4  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Diethyl sebacate.............        110-40-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Diethyl tartrate.............         87-91-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
3,7-Dimethyl-6-octenoic acid.        502-47-6  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Dimethylcyclohex-3-ene-1-          27939-60-2  When ready for use, the
 carbaldehyde.                                  end-use concentration is
                                                not to exceed 100 ppm.
[alpha],[alpha]-                     100-86-7  When ready for use, the
 Dimethylphenethyl alcohol.                     end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
[gamma]-Dodecalactone........       2305-05-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
[delta]-Dodecalactone........        713-95-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
2-Dodecenal..................       4826-62-4  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Ethyl formate................        109-94-4  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Ethyl 2-hexylacetoacetate....      29214-60-6  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Ethyl 3-hydroxybutyrate......       5405-41-4  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Ethyl isovalerate............        108-64-5  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Ethyl levulinate.............        539-88-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Ethyl 2-methyl-3-pentenoate..       1617-23-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Ethyl 2-methylpentanoate.....      39255-32-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Ethyl propionate.............        105-37-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Ethyl tiglate................       5837-78-5  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Farnesol.....................       4602-84-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Farnesyl acetate.............      29548-30-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
2-Formyl-6,6-                        564-94-3  When ready for use, the
 dimethylbicyclo(3.1.1)hept-2-                  end-use concentration is
 ene.                                           not to exceed 100 ppm.
Geranic acid.................        459-80-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Geraniol.....................        106-24-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Geranyl butyrate.............        106-29-6  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Geranyl formate..............        105-86-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Geranyl isobutyrate..........       2345-26-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Geranyl propionate...........        105-90-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Geranyl tiglate..............       7785-33-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Helichrysum leaf oil                8023-95-8  When ready for use, the
 (Helichrysum angustifolium).                   end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
trans-3-Heptenyl 2-                67801-45-0  When ready for use, the
 methylpropanoate.                              end-use concentration is
                                                not to exceed 100 ppm.
Heptyl acetate...............        112-06-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Hexadecanoic acid............         57-10-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Hexadecanoic acid, ethyl             628-97-7  When ready for use, the
 ester.                                         end-use concentration is
                                                not to exceed 100 ppm.
[omega]-6-Hexadecenlactone...       7779-50-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
2,4-Hexadienyl isobutyrate...      16491-24-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
1-Hexanol, 3,5,5-trimethyl-..       3452-97-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
2-Hexen-1-ol.................       2305-21-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
3-Hexen-1-ol, (3Z)-..........        928-96-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
(E)-2-Hexen-1-yl acetate.....       2497-18-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
cis-3-Hexenyl isobutyrate....      41519-23-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
cis-3-Hexenyl propionate.....      33467-74-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
cis-3-Hexenyl tiglate........      67883-79-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
3-Hexenyl formate............        9/5/2315  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Hexyl 2-methylbutanoate......      10032-15-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Hexyl octanoate..............       1117-55-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Hydroxycitronellal dimethyl          141-92-4  When ready for use, the
 acetal.                                        end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Hyssop oil (Hyssopus                8006-83-5  When ready for use, the
 officinalis L.).                               end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *

                              * * * * * * *
Isoamyl isovalerate..........        659-70-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Isoamyl propionate...........        105-68-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Isobutyl angelate............       7779-81-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Isobutyl 2-butenoate.........        589-66-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Isobutyl butyrate............        539-90-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Isobutyraldehyde.............         78-84-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Isobutyric acid..............         79-31-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Isovaleric acid..............        503-74-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Jasmine lactone..............      25524-95-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
laevo-Bornyl acetate.........       5655-61-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Lauryl acetate...............        112-66-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Levulinic acid...............        123-76-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Linalool acetate.............        115-95-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Linalyl formate..............        115-99-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Linalyl hexanoate............       7779-23-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Linalyl isobutyrate..........         78-35-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Linalyl isovalerate..........       1118-27-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Linalyl propionate...........        144-39-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Linoleic acid, methyl ester..        112-63-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Lovage oil (Levisticum              8016-31-7  When ready for use, the
 officinale Koch).                              end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
p-Mentha-1,8-dien-7-ol.......        536-59-4  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

p-Mentha-1,8-dien-7-yl             15111-96-3  When ready for use, the
 acetate.                                       end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
1H-3a,7-Methanoazulen-6-ol,           77-53-2  When ready for use, the
 octahydro-3,6,8,8-                             end-use concentration is
 tetramethyl-,[3R-                              not to exceed 100 ppm.
 (3.[alpha],3a.[beta],6.[alph
 a],7.[beta],8a[alpha])].

                              * * * * * * *
3-Methyl-2-buten-1-ol........        556-82-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
2-Methyl butyl acetate.......        624-41-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
3-Methylbutyraldehyde........        590-86-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Methyl butyrate..............        623-42-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
2-Methylbutyric acid.........        116-53-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
3-Methylcrotonic acid........        541-47-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Methyl 3,7-dimethyl-6-              2270-60-2  When ready for use, the
 octenoate.                                     end-use concentration is
                                                not to exceed 100 ppm.
Methyl hexanoate.............        106-70-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Methyl linolenate............        301-00-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Methyl 2-methylbutyrate......        868-57-5  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Methyl 3-nonenoate...........      13481-87-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
2-Methyloctanal..............       7786-29-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Methyl octanoate.............        111-11-5  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
2-Methylpent-2-en-1-oic acid.       3142-72-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Methyl tetradecanoate........        124-10-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
2-Methyl-trans-2-butenoic             80-59-1  When ready for use, the
 acid.                                          end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Methyl undec-10-enoate.......        111-81-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Musk ambrette................        123-69-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Nerolidiol...................        142-50-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Neryl formate................       2142-94-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
2,6-Nonadien-1-ol............       7786-44-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
2,6-Nonadienal diethyl acetal      67674-36-6  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
1,3-Nonanediol acetate (mixed       1322-17-4  When ready for use, the
 esters).                                       end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
2-Nonenal....................       2463-53-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Nonyl acetate................        143-13-5  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Octadecanoic acid............         57-11-4  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
[delta]-Octalactone..........        698-76-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
2,5,7-Octatrien-1-ol, 2,6-        197098-61-6  When ready for use, the
 dimethyl0, 1-acetate.                          end-use concentration is
                                                not to exceed 100 ppm.
5-Octen-1-ol, (5Z)-..........      64275-73-6  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Oil of citronella............       8000-29-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Oils, geranium...............       8000-46-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Oils, lavender...............       8000-28-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Oils, lemon, terpene-free....      68648-39-5  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Oils, palmarosa..............       8014-19-5  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Oleic acid...................        112-80-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Oleic acid, ethyl ester......        111-62-6  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Oleyl alcohol................        143-28-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Orange flower water absolute.       8030-28-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Oxacycloheptadec-10-ene-2-one      28645-51-4  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
1-pentanol...................         71-41-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Petitgrain Paraguay oil......       8014-17-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Propanoic acid...............         79-09-4  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *

                              * * * * * * *
Pyruvic acid.................        127-17-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Sandalwood yellow oil               8006-87-9  When ready for use, the
 (Santalum album L.).                           end-use concentration is
                                                not to exceed 100 ppm.
Santalol.....................      11031-45-1  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
cis-[alpha]-Santalol.........        115-71-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
cis-[beta]-Santalol..........         77-42-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Sclareol.....................        515-03-7  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Spike lavender oil (Lavandula       8016-78-2  When ready for use, the
 spp.).                                         end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Tartaric acid................         87-69-4  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
DL-Tartaric acid.............        133-37-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
[alpha]-Terpinyl propionate..         80-27-3  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
Tetradecanoic acid, ethyl            124-06-1  When ready for use, the
 ester.                                         end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Tetrahydrogeranial...........       5988-91-0  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
2,6,6-Trimethyl-1-cyclohexen-        472-66-2  When ready for use, the
 1-acetaldehyde.                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
2,6,6-Trimethyl-1&2-                 432-25-7  When ready for use, the
 cyclohexen-1-carboxaldehyde.                   end-use concentration is
                                                not to exceed 100 ppm.
p-[alpha],[alpha]-                  1197-01-9  When ready for use, the
 Trimethylbenzyl alcohol.                       end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
9-Undecenal..................        143-14-6  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
10-Undecenal.................        112-45-8  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
10-Undecenoic acid...........        112-38-9  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.
10-Undecenoic acid, ethyl            692-86-4  When ready for use, the
 ester.                                         end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
[gamma] -Valerolactone.......        108-29-2  When ready for use, the
                                                end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
Violet leaves absolute (Viola      90147-36-7  When ready for use, the
 odorata L.).                                   end-use concentration is
                                                not to exceed 100 ppm.

                              * * * * * * *
------------------------------------------------------------------------

* * * * *
[FR Doc. 2023-03830 Filed 3-10-23; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 78, Number 212 (Friday, November 1, 2013)]
[Notices]
[Pages 65734-65736]
[FR Doc No: 2013-26033]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-70761; File No. SR-Topaz-2013-09]

Self-Regulatory Organizations; Topaz Exchange LLC; Notice of
Filing and Immediate Effectiveness of Proposed Rule Change To Amend the
Schedule of Fees

October 28, 2013.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(the ``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given
that on October 22, 2013, the Topaz Exchange, LLC (d/b/a ISE Gemini)
(the ``Exchange'' or ``Topaz'') filed with the Securities and Exchange
Commission the proposed rule change, as described in Items I, II, and
III below, which items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    Topaz is proposing to amend its Schedule of Fees to adopt a
continuing education fee for Series 56 registered persons. The text of
the proposed rule change is available on the Exchange's Internet Web
site at http://www.ise.com, at the principal office of the Exchange,
and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of, and basis for, the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in
Item IV below. The self-regulatory organization has prepared summaries,
set forth in Sections A, B and C below, of the most significant aspects
of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The purpose of the proposed rule change is to amend the Schedule of
Fees to adopt a fee for a new continuing

education program, the S501,\3\ which is required for persons who are
registered as Proprietary Traders (i.e. Series 56) and do not maintain
any other registration.\4\
---------------------------------------------------------------------------

    \3\ See Securities Exchange Act Release No. 70417 (September 16,
2013), 78 FR 57907 (September 20, 2013) (SR-ISE-2013-48). ISE Rule
604, which specifies the continuing education requirements for
registered persons, including Series 56 registered Proprietary
Traders, is incorporated by reference into Chapter 6 of Topaz Rules.
    \4\ Individuals that are registered under any other registration
are required to maintain the continuing education obligations
associated with such registrations. For example, an individual that
engages solely in proprietary trading activities but has passed the
Series 7 and is registered as a General Securities Representative
will be required to continue taking the Series 7 continuing
education program (S101). Id.
---------------------------------------------------------------------------

    The S501 addresses the continuing education of Proprietary Traders,
based on the content outline for the Series 56 exam, which covers the
main categories of rules and regulations generally applicable to such
persons. These generally include recordkeeping and recording
requirements, types and characteristics of securities and investments,
trading practices and display execution and trading systems. Each
Proprietary Trader required to take the S501 must complete the
continuing education program within 120 days after their [sic] second
registration anniversary date, and every three years thereafter or as
otherwise prescribed by the Exchange.
    The Exchange proposes to adopt a $60 fee for the S501 continuing
education program, which will be used for the administration of the
S501. The Financial Industry Regulatory Authority (``FINRA'')
administers this program on behalf of the exchanges and therefore the
fees are payable directly to FINRA. The Exchange expects that the other
exchanges that recognize the Proprietary Trader registration either
have or will adopt the same fee for continuing education.\5\
---------------------------------------------------------------------------

    \5\ See e.g. Securities Exchange Act Release Nos. 70257 (August
26, 2013), 78 FR 53814 (August 30, 2013) (SR-BATS-2013-047); 70064
(July 30, 2013), 78 FR 47469 (August 5, 2013) (SR-CBOE-2013-078);
70194 (August 14, 2013) 78 FR 51259 (August 20, 2013) (SR-C2-2013-
030); 70327 (September 5, 2013), 78 FR 55766 (September 11, 2013)
(SR-Phlx-2013-85).
---------------------------------------------------------------------------

    The Exchange's Schedule of Fees does not currently set forth the
session fees for other continuing education programs required by the
Exchange because these programs are within the jurisdiction of FINRA,
which collects these session fees from its members. The Series 56,
however, applies to Topaz Members that are not required by Section
15(b)(8) of the Act \6\ to become members of FINRA. Therefore, the
Exchange believes it is appropriate to include the Series 56 continuing
education fee within the Exchange's Schedule of Fees to make the cost
of this program clear to Topaz Members.
---------------------------------------------------------------------------

    \6\ 15 U.S.C. 78o(b)(8).
---------------------------------------------------------------------------

2. Statutory Basis
    The Exchange believes that its proposal is consistent with Section
6(b) of the Act,\7\ in general, and furthers the objectives of Section
6(b)(4) of the Act,\8\ in particular, in that it provides for an
equitable allocation of reasonable fees and other charges among
Exchange Members and other persons using its facilities. The proposed
fee is equitable and not unfairly discriminatory, because it applies
equally to all persons registered solely as Proprietary Traders. The
Exchange notes that it will not invoice or collect funds from Members
that are subject to these fees because these fees will be paid directly
to FINRA as administrator of the continuing education program. The
proposed fees are reasonably designed to allow FINRA to cover its cost
of administering the Series 56 continuing education program on behalf
of the Exchange, and the Exchange believes it is reasonable and
equitable to include these fees in its Schedule of Fees to make the
costs of the Series 56 continuing education program clear to Members.
Moreover, the Exchange believes other exchanges will be assessing the
same fees for this continuing education program.\9\
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78f(b).
    \8\ 15 U.S.C. 78f(b)(4).
    \9\ See supra notes 3 and 5.
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act. The Exchange does not
believe that the proposed rule change will affect intermarket
competition because all of the exchanges that recognize the Proprietary
Trader registration category are expected to adopt the same continuing
education fee.\10\ Furthermore, the Exchange does not believe the
proposed rule change will affect intramarket competition because all
Proprietary Traders required to complete the new S501 continuing
education program will pay the same continuing education fee.
---------------------------------------------------------------------------

    \10\ Id.
---------------------------------------------------------------------------

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others

    The Exchange has not solicited, and does not intend to solicit,
comments on this proposed rule change. The Exchange has not received
any unsolicited written comments from members or other interested
parties.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The foregoing rule change has become effective pursuant to Section
19(b)(3)(A)(ii) of the Act,\11\ and subparagraph (f)(2) of Rule 19b-4
thereunder,\12\ because it establishes a due, fee, or other charge
imposed by Topaz.
---------------------------------------------------------------------------

    \11\ 15 U.S.C. 78s(b)(3)(A)(ii).
    \12\ 17 CFR 240.19b-4(f)(2).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of such proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act. If the Commission
takes such action, the Commission shall institute proceedings to
determine whether the proposed rule should be approved or disapproved.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-Topaz-2013-09 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-Topaz-2013-09. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's

Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the
submission, all subsequent amendments, all written statements with
respect to the proposed rule change that are filed with the Commission,
and all written communications relating to the proposed rule change
between the Commission and any person, other than those that may be
withheld from the public in accordance with the provisions of 5 U.S.C.
552, will be available for Web site viewing and printing in the
Commission's Public Reference Room, 100 F Street NE., Washington, DC
20549, on official business days between the hours of 10:00 a.m. and
3:00 p.m. Copies of such filing also will be available for inspection
and copying at the principal office of the Exchange. All comments
received will be posted without change; the Commission does not edit
personal identifying information from submissions. You should submit
only information that you wish to make available publicly. All
submissions should refer to File Number SR-Topaz-2013-09 and should be
submitted on or before November 22, 2013.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\13\
---------------------------------------------------------------------------

    \13\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2013-26033 Filed 10-31-13; 8:45 am]
BILLING CODE 8011-01-P